Type 2 DM Pharmacotherapy Selection Update and Management Considerations for Older Adults: Key updates related to T2DM pharmacotherapy from the 2023 ADA guideline include the following: Further emphasis for selecting pharmacotherapy (first-line and add-on therapies) based upon patient specific factors, comorbidities, and treatment goals (e.g., cardiorenal risk reduction in high-risk patients, glycemic and weight management, access, etc.)
Cephalalgia 39(13):16751682 Noseda R, Kainz V, Borsook D, Burstein R (2014) Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety
If you haven't already, I would meet with a registered dietician to go over your eating habits
How long a vial lasts will depend on how much you need to inject each week
Many encounter hurdles associated with prescription rules, insurance rules, and out-of-pocket costs
Wawrzenczyk A, Nalecz KA, Nalecz MJ